The modern antiretroviral treatment of human immunodeficiency virus (HIV-1) infection has
considerably lowered the incidence of opportunistic infections. With the exception of the …

Background: The HIV associated mortality is decreasing in most countries due to the
widespread use of antiretroviral therapy. However, HIV-associated neurocognitive disorder …

Evidence-based guidelines for the management of persons infected with human
immunodeficiency virus (HIV) were prepared by an expert panel of the HIV Medicine …

Neurological involvement in HIV is often associated with cognitive impairment. Although
severe and progressive neurocognitive impairment has become rare in HIV clinics in the era …

Cross-sectional studies show that around half of individuals infected with HIV-1 have some
degree of cognitive impairment despite the use of antiretroviral drugs. However, prevalence …

Current approaches to classifying cognitive impairment in people living with HIV can
overestimate disease burden and lead to ambiguity around disease mechanisms. The 2007 …

Depression, alcohol use disorders (AUD), and neurocognitive disorders are the 3 most
prevalent mental, neurological, and substance use disorders in people living with HIV …

Human immunodeficiency virus (HIV) is a chronic infectious disease currently requiring
lifelong antiretroviral therapy (ART). People living with HIV (PLWH) face an increased risk of …

The prevalence of HIV (human immunodeficiency virus) associated neurocognitive
disorders (HAND) will undoubtedly increase with the improved longevity of HIV-infected …

Quality of life (QoL) is recognized as an essential end point in the disease management of
chronic conditions such as HIV with calls to include good QoL as a 'fourth 90'in the 90-90-90 …